Cardiff Oncology
CRDF
CRDF
55 hedge funds and large institutions have $11.6M invested in Cardiff Oncology in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 7 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
85% less call options, than puts
Call options by funds: $37K | Put options by funds: $251K
Holders
55
Holding in Top 10
–
Calls
$37K
Puts
$251K
Top Buyers
| 1 | +$1.07M | |
| 2 | +$355K | |
| 3 | +$78K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$68.4K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$36.5K |
Top Sellers
| 1 | -$1.05M | |
| 2 | -$314K | |
| 3 | -$264K | |
| 4 |
Mercer Global Advisors
Denver,
Colorado
|
-$207K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$138K |